Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7D8N

Structure of the inactive form of wild-type peptidylarginine deiminase type III (PAD3) crystallized under the condition with high concentrations of Ca2+

Summary for 7D8N
Entry DOI10.2210/pdb7d8n/pdb
Related7D4Y 7D56 7D5R 7D5V
DescriptorProtein-arginine deiminase type-3, CALCIUM ION, GLYCEROL, ... (5 entities in total)
Functional Keywordscitrullination, inactive, isozyme, post-translational modification, calcium ion, hydrolase
Biological sourceHomo sapiens (Human)
Total number of polymer chains2
Total formula weight150774.55
Authors
Funabashi, K.,Sawata, M.,Unno, M. (deposition date: 2020-10-08, release date: 2021-06-02, Last modification date: 2023-11-29)
Primary citationFunabashi, K.,Sawata, M.,Nagai, A.,Akimoto, M.,Mashimo, R.,Takahara, H.,Kizawa, K.,Thompson, P.R.,Ite, K.,Kitanishi, K.,Unno, M.
Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Arch.Biochem.Biophys., 708:108911-108911, 2021
Cited by
PubMed Abstract: Peptidylarginine deiminase type III (PAD3) is an isozyme belonging to the PAD enzyme family that converts arginine to citrulline residue(s) within proteins. PAD3 is expressed in most differentiated keratinocytes of the epidermis and hair follicles, while S100A3, trichohyalin, and filaggrin are its principal substrates. In this study, the X-ray crystal structures of PAD3 in six states, including its complex with the PAD inhibitor Cl-amidine, were determined. This structural analysis identified a large space around Gly374 in the PAD3-Ca-Cl-amidine complex, which may be used to develop novel PAD3-selective inhibitors. In addition, similarities between PAD3 and PAD4 were found based on the investigation of PAD4 reactivity with S100A3 in vitro. A comparison of the structures of PAD1, PAD2, PAD3, and PAD4 implied that the flexibility of the structures around the active site may lead to different substrate selectivity among these PAD isozymes.
PubMed: 33971157
DOI: 10.1016/j.abb.2021.108911
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.753 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon